Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 24, 2008Journal of Medicinal ChemistryOpen Access

Discovery of Novel Small-Molecule Inhibitors of Human Epidermal Growth Factor Receptor-2: Combined Ligand and Target-Based Approach

View Full Paper
Ask AI
Bookmark
Share

Authors

RGRambabu GundlaUniversity of HyderabadRKRoza KazemiUniversity of Southern CaliforniaRSRamadevi SanamJawaharlal Nehru Technological University, Hyderabad

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gundla et al. (2008) studied this question.

synapsesocial.com/papers/6a9a0cb24e49e699219e4c5bhttps://doi.org/10.1021/jm7013875
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Evaluation of 8-Arylsulfanyl, 8-Arylsulfoxyl, and 8-Arylsulfonyl Adenine Derivatives as Inhibitors of the Heat Shock Protein 902005 · 193 citations
  2. 26-Substituted-4-(3-bromophenylamino)quinazolines as Putative Irreversible Inhibitors of the Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor (HER-2) Tyrosine Kinases with Enhanced Antitumor Activity2001 · 274 citations
  3. 3Tyrosine Kinase Inhibitors. 18. 6-Substituted 4-Anilinoquinazolines and 4-Anilinopyrido[3,4-d]pyrimidines as Soluble, Irreversible Inhibitors of the Epidermal Growth Factor Receptor2000 · 90 citations
  4. 4Poling: Promoting conformational variation1995 · 444 citations
  5. 5Combining ligand-based and structure-based drug design in the virtual screening arena2007 · 24 citations